Form 483

Elite Laboratories Inc. Form 483, 2020-03-13

FDA issued a Form 483 to Elite Laboratories Inc. on 2020-03-13 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

Elite Laboratories Inc. · Northvale, United States · Issued March 13, 2020

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

13 Mar 2020
FDCA 505-1(e)(3)

Failure to comply with REMS Communication Plan

Cited by Michael Serrano

Inspected site

ELElite Laboratories Inc.Northvale, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
FDCA 505-1(e)(3)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere